These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9733047)

  • 1. PTEN and prostate cancer.
    Facher EA; Law JC
    J Med Genet; 1998 Sep; 35(9):790. PubMed ID: 9733047
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
    Wang SI; Parsons R; Ittmann M
    Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
    Whang YE; Wu X; Sawyers CL
    J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
    [No Abstract]   [Full Text] [Related]  

  • 7. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
    Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
    Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN and inherited hamartoma-cancer syndromes.
    Eng C; Peacocke M
    Nat Genet; 1998 Jul; 19(3):223. PubMed ID: 9662392
    [No Abstract]   [Full Text] [Related]  

  • 9. [Involvement of protein tyrosine phosphatases in cancer development].
    Hinoda Y; Idogawa M; Imai K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1186-92. PubMed ID: 9655978
    [No Abstract]   [Full Text] [Related]  

  • 10. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
    Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
    Chen J; Lindblom P; Lindblom A
    Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
    Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
    Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.
    George DJ; Shepard TF; Ma J; Giovannucci E; Kantoff PW; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):411-2. PubMed ID: 11319185
    [No Abstract]   [Full Text] [Related]  

  • 16. PTEN germ-line mutations in juvenile polyposis coli.
    Olschwang S; Serova-Sinilnikova OM; Lenoir GM; Thomas G
    Nat Genet; 1998 Jan; 18(1):12-4. PubMed ID: 9425889
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pten, a candidate tumor suppressor gene, maps to mouse chromosome 19.
    Hansen GM; Justice MJ
    Mamm Genome; 1998 Jan; 9(1):88-90. PubMed ID: 9434957
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of germline PTEN mutations in familial prostate cancer.
    Forrest MS; Edwards SM; Hamoudi RA; Dearnaley DP; Arden-Jones A; Dowe A; Murkin A; Kelly J; Teare MD; Easton DF; Knowles MA; Bishop DT; Eeles RA
    J Med Genet; 2000 Mar; 37(3):210-2. PubMed ID: 10777362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.